Cargando…
Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer
Multidrug resistance (MDR), mainly mediated by ABCB1 transporter, is a major cause for chemotherapy failure. Bufalin (BU), an active component of the traditional Chinese medicine chan’su, has been reported to have antitumor effects on various types of cancer cells. The purpose of this present study...
Autores principales: | Yuan, Ze-Ting, Shi, Xiao-Jing, Yuan, Yu-Xia, Qiu, Yan-Yan, Zou, Yu, Liu, Cheng, Yu, Hui, He, Xue, Xu, Ke, Yin, Pei-Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564622/ https://www.ncbi.nlm.nih.gov/pubmed/28624793 http://dx.doi.org/10.18632/oncotarget.18225 |
Ejemplares similares
-
Bufalin reverses ABCB1-mediated resistance to docetaxel in breast cancer
por: Zhang, Die, et al.
Publicado: (2023) -
Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells
por: Sun, Jian, et al.
Publicado: (2017) -
Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor‐κB/MDR1 pathway in colorectal cancer
por: Zhan, Yueping, et al.
Publicado: (2020) -
Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
por: Fang, Kai, et al.
Publicado: (2021) -
Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells
por: Qiu, Dong-Ze, et al.
Publicado: (2013)